chr22-23779272-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005940.5(MMP11):c.194C>T(p.Thr65Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000491 in 1,609,804 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005940.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152232Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000509 AC: 12AN: 235566Hom.: 0 AF XY: 0.0000465 AC XY: 6AN XY: 129168
GnomAD4 exome AF: 0.0000377 AC: 55AN: 1457454Hom.: 0 Cov.: 33 AF XY: 0.0000386 AC XY: 28AN XY: 724746
GnomAD4 genome AF: 0.000158 AC: 24AN: 152350Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74508
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2021 | The c.194C>T (p.T65M) alteration is located in exon 2 (coding exon 2) of the MMP11 gene. This alteration results from a C to T substitution at nucleotide position 194, causing the threonine (T) at amino acid position 65 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at